.After antibody-drug conjugate (ADC) specialist Seagen was actually sold to Pfizer in 2015 for an im...
.On the heels of a phase 3 win that neglected to make an impression on real estate investors, Ironwo...
.Don't stop Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after authorizing...
.Welcome to today's Chutes & Ladders, our roundup of significant management hirings, firings and ...
.Commemorating his business's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the pos...
.AbbVie has actually come back to the resource of its own antipsychotic goliath Vraylar seeking anot...
.GenSight Biologics is actually full weeks out of losing money. Once again. The biotech only possess...
.Monopar Rehabs is recuperating a medication coming from the dump of AstraZeneca's rare illness pipe...
.Along with new records out on Arcus Biosciences' speculative HIF-2a inhibitor, one group of experts...
.After creating a gene treatment collaboration along with Dyno Therapeutics in 2020, Roche is actual...